Emerging evidence has identified sleep as a significant, but modifiable, risk factor for metabolic syndrome, diabetes, and obesity. Leptin, an adipocyte-derived peptide and a regulator of food intake and energy expenditure, has been shown to be associated with a short sleep duration in the pathophysiology of obesity and consequently type 2 diabetes. This review focuses on the current evidence indicating the effects of a short sleep duration on the regulation of leptin concentration in association with obesity and diabetes mellitus. In summary, the evidence suggests that sleep deprivation, by affecting leptin regulation, may lead to obesity and consequently development of type 2 diabetes through increased appetite and food intake. However, findings on the role of leptin in diabetes due to sleep deprivation are contradictory, and further studies with larger sample sizes are needed to confirm previous findings.

Sleep is a biological and behavioral process that is fundamental for life and optimum health. Sleep is controlled by diurnal, homeostatic, and neurohormonal mechanisms [1]. Existing research acknowledges that sleep is an essential modulator of cardiovascular function, glucose regulation, and hormonal release [2]. Sleep duration has also been shown to have a pivotal function in metabolic hormones and body weight and it has been linked to other biological mechanisms including inflammation, the autonomic nervous system, the coagulation system, endothelial function, and metabolic regulation [3, 4]. Sleep quality varies in individuals according to factors such as age, gender, occupation, educational level, socioeconomic status, race, family relationships, and pathological conditions including insomnia, depression level, and sleep-disordered breathing [5-7]. According to the US National Sleep Foundation, adequate sleep duration requirements vary across lifespans and from person to person, with 7–9 h recommended for adults [8, 9]. In recent decades, the average sleep duration has decreased worldwide, and this is widely attributed to a modern lifestyle [10]. Based on National Sleep Foundation criteria, 75% of preadolescents and 45% of late adolescents experience sleep deficiency [11].

Insufficient sleep is characterized by either a considerable reduction in sleep time during a certain period due to 24-h wakefulness or a reduction in sleep time less than the optimal level for individual needs. Sleep loss, related to a decreased total sleep time, can be a result of habitual behavior or the presence of a pathological condition including addiction (medications or alcohol), anxiety, depression, idiopathic, somatic and painful diseases, and subjective and psychophysiological insomnia [12].

The reports from recent epidemiological studies, meta-analyses, and systematic reviews have indicated that sleep duration is significantly correlated with several adverse health outcomes including diabetes mellitus, cardiovascular diseases, coronary heart diseases and stroke, dyslipidemia, hypertension, metabolic disease, obesity, and mortality [1, 13-20]. Recent evidence proposes that that relationship between a short sleep duration, obesity, and diabetes risk may include at least 3 pathways, i.e., (1) an altered glucose metabolism, (2) up-regulation of hunger and appetite or dysregulation of appetite/satiety hormones, and (3) down-regulation of energy expenditure [21].

Leptin, a metabolic hormone, has a pivotal function in balancing appetite and satiety via food intake regulation and energy homeostasis [22]. Leptin works in synergy with another metabolic hormone, i.e., ghrelin. Whereas leptin suppresses food intake and induces weight loss, ghrelin increasing hunger and food intake [22]. Leptin is the product of the ob gene, which has an impact on growth, metabolism, and reproduction [23, 24]. Leptin has several other biological roles in the body [24], including functions in glucose homeostasis via suppression of insulin production in pancreatic β cells [25]. The regulation of diurnal blood leptin is controlled by multiple factors such as gender, age, feeding, fasting, sleep, obesity, and endocrine disorders [26]. The concentration of serum leptin is directly related to fat mass, where increased circulating leptin, termed leptin resistance, is related to obesity [27]. The proposed mechanisms involved in leptin resistance are comprised of a reduction in the number of leptin receptors, impairment of receptor function, a reduction in transport across the blood-brain barrier, and a circulating suppressor of leptin function [28]. Since a leptin deficit in lipodystrophy is accompanied by dysglycemia and insulin resistance, it is expected that glucose metabolism is affected by leptin resistance [28]. Defects or dysfunction in the leptin signaling pathway plays a role in the pathophysiology of obesity, diabetes mellitus, and cardiovascular disease, and downstream targets of leptin may have a therapeutic potential role in the management of diabetes [29, 30]. Furthermore, the adiponectin-leptin ratio has been found to be significantly correlated with the insulin resistance index in diabetes mellitus [31-33]. Leptin stimulates cytokine activation and immune-cell proliferation, which predisposes to inflammatory conditions [34].

The evidence suggests a bidirectional relationship between sleep duration and leptin. Leptin has central neural specific effects beyond modulation of appetite alone [35]. Leptin concentrations display a circadian pattern, with its levels increasing during the first part of the night and then decreasing during the latter part of the night [36]. Furthermore, leptin has a function in preserving deep sleep by antagonizing the orexin neuron function in the hypothalamus [37]. The findings of animal studies presented that the orexin (hypocretin) system monitors sleep and wakefulness through interactions with the system that regulates energy homeostasis and facilitates adaptive intensification of arousal in response to fasting. The orexin neuron actions are inhibited by leptin, blood glucose, and food intake [37-39]. An animal study in leptin-resistant (db/db) genetically obese and diabetic mice showed that impaired leptin signaling had deleterious impacts on the regulation of sleep duration [40]. This study proposed that leptin signaling plays an important role in coordination of sleep-wake states and metabolism. It appears that sleep-related changes in leptin level promote progression of metabolic and immune disorders. Leptin’s proinflammatory role [24, 41, 42] proposes that increased serum leptin levels in metabolic syndrome and obesity in a sleep deprivation status may be associated with low-grade systemic inflammatory diseases, characterized by increased proinflammatory cytokine levels including interleukin-6 and tumor necrosis factor (TNF)-α. Leptin regulates the brain appetite-regulating center with information about energy balance [43]. It has been believed that there is an interaction between leptin and insulin in peripheral tissues [44, 45]. Leptin inhibits energy storage mechanisms, whereas insulin enhances leptin production [46]. Evidence also indicates that leptin promotes insulin sensitivity through enhancement of fatty acid oxidation and declined fat accumulation in non-adipose tissues. Leptin induces fatty acid oxidation in muscle via AMP-activated protein kinase (AMPK) [47]. Moreover, leptin has a significant role in increasing the glucose uptake in skeletal muscle through a β-adrenergic mechanism and the hypothalamic-sympathetic nervous system axis [47].

As one of the factors affecting leptin level regulation, the effect of sleep has been investigated in several experimental studies. Sleep loss with an effect on appetite hormone (leptin) and energy expenditure has been linked to an increased risk of obesity and diabetes. This review aims to provide an update on the influence of short sleep duration on leptin levels in association with obesity and diabetes mellitus.

PubMed, Google Scholar, and Science Direct were searched using the following terms: “leptin,” “sleep duration,” “sleep length,” “sleep period,” “sleep deprivation,” “sleep deficiency,” “sleep curtailment,” “sleep loss,” “short sleep duration,” “diabetes,” “weight gain,” and “obesity.” Original articles, reviews, and conference abstracts were included. Hand searching of reference lists was undertaken to identify any additional eligible studies. Publication dates were limited to 2000–2020, and papers written in English were included.

Obesity, the result of a modern lifestyle, has progressively increased globally over the past century. The obesity epidemic and its consequent metabolic dysfunctions have been paralleled by the reduction in sleep duration [48, 49]. It has been suggested by recent studies that sleep restriction adversely affects metabolic homeostasis, leading to increased hunger and appetite, and food intake, which consequently leads to insulin resistance [49, 50]. The appetite hormones ghrelin and leptin work in synergy to manage hunger and satiety. Ghrelin, a stomach-derived peptide, increases appetite [51], while leptin sends a message to the brain and suppresses appetite [52]. Appetite hormones rise throughout the day to a peak at 1:00 p.m. and then decrease overnight to a nadir at 9:00 p.m., which might be the cause of low leptin levels in short sleepers [53]. It has been proposed that dysregulated leptin and ghrelin play a key role in the increased BMI in short sleepers [4]. In an early study by Spiegel et al. [54], 2 days of sleep restriction (4 h) reduced leptin (18%) and elevated ghrelin levels (28%), indicative of an enhanced drive to eat (hunger, 24%; appetite, 23%) in young, healthy men. A study by Taheri et al. [4] showed that sleep duration below 7.7 h was associated with decreased leptin and increased ghrelin concentrations and consequently an increased body mass. These researchers suggested that a leptin deficiency increases appetite and consequently may cause obesity. The Child and Adolescent Metabolic Syndrome cohort studies [55, 56] suggested that a short sleep duration (<8 h/day), compared to a long (≥10 h/day) sleep duration, affects the association of polygenic risk for obesity and the leptin pathway explains a key mechanism through a modification effect.

Thus far, there are conflicting results regarding leptin circulation in sleep curtailment, with its level being shown to be reduced [4, 57-59], unchanged [60-62], or elevated [63-67]. Chaput et al. [57], in their study in adults, reported that a sleep duration of 5–6 h/day was associated with a reduction in leptin levels and an increased risk of obesity and overweight compared to 7–8 and 9–10 h/day. A study in postmenopausal women showed that a sleep duration of less than 6 h per night was associated with lower serum leptin level compared to a sleep duration of more than 8 h [59]. In a study in healthy men, Mullington et al. [58] reported a rapid reduction in leptin amplitude in that sleep deprivation period, which returned toward normal during the period of recovery sleep. Spiegel et al. [68] evaluated associations between leptin and sympathovagal balance, cortisol, thyroid-stimulating hormone (thyrotropin or TSH), glucose, and insulin under different bedtime conditions. They reported that sleep restriction (4 h for 6 nights) was associated with a decrease in the mean and maximal levels and rhythm amplitude of leptin (–19, −26, and –20%, respectively) compared to an extended sleep time (12 h for 7 nights). The effects of a short sleep duration on leptin level have also been shown to be associated with an elevation of sympathovagal balance and alterations in the cortisol and TSH profiles [68]. The thyroid gland regulates thermogenesis (body temperature) and appetite, and its dysfunction (hypothyroidism or hyperthyroidism) results in alterations in body mass [69]. Furthermore, higher TSH levels are associated with obesity and a higher body mass [70-72]. The exact mechanism underlying the influence of TSH on obesity is still unclear, but increases in energy expenditure and hyperleptinemia have been proposed to be influenced in this relationship [69].

Although short-term sleep curtailment has been shown to be associated with activation of the stress system, which leads to decreased leptin levels and increased hunger and appetite, acute loss of sleep in a less stressful environment has been shown to increase leptin levels in the body [66]. Therefore, it seems that a combination of sleep curtailment and activation of the stress system but not sleep loss itself may lead to decreased leptin levels and increased hunger [66]. Hayes et al. [65] have examined the level of leptin in association with a reduced sleep time among adults. They reported that a 1-h decrease in total sleep duration was associated with a 10% increase in leptin levels [65]. A study on salivary cortisol and leptin in young healthy women showed that a single night of restricted sleep (3 h) altered the diurnal pattern of cortisol rhythms (the level of morning cortisol was reduced, and afternoon/evening cortisol levels were elevated) and increased morning leptin levels in subjects but it did not have an effect on hunger and craving scores [67]. Bosy-Westphal et al. [73] found that consecutive nightly decreases in sleep duration significantly increased body weight, energy intake, glucose-induced thermogenesis, leptin/fat mass, free triiodothyronine, and free thyroxine [73]. Charles et al. [74] showed that both short (<5 h) and long (>8 h) sleep durations were associated with increased leptin levels related to obesity.

However, unaffected leptin levels have been reported in patients with a sleep deficiency [61]. In a study in men with and without insomnia, circulating levels of leptin and ghrelin were measured across the night. Serial measurement of appetite hormones showed that ghrelin levels were significantly lower in insomnia patients, whereas leptin did not differ between the groups. Furthermore, the findings of this study concluded that dysregulation in energy balance in patients with insomnia results in weight gain in this population [61]. A Circadian Locomotor Output Cycles Kaput(CLOCK) gene study showed that a shorter sleep duration increased ghrelin levels with no effects on leptin values [60]. This study suggested that sleep reduction with alterations in ghrelin levels and changes in eating behaviors may affect weight and weight loss. Schmid et al. [62], in a study in healthy normal-weight men, reported that feelings of hunger and ghrelin levels were elevated after 1 night of total sleep deprivation, whereas morning serum leptin concentrations was unaffected. A large multiethnic study also found no association between sleep duration and leptin levels [75].

Sleep plays a critical role in glucose regulation, and sleep duration has been shown to have an inverse effect on endocrine function and carbohydrate metabolism [2, 76]. The link between sleep and glucose metabolism has been explored in several studies, where it has been proposed that both short [13, 77-80] and long sleep durations [81-83] may increase the risk of developing obesity and consequently diabetes mellitus. It was shown by a systematic and meta-analysis study that both short and long sleep durations in type 2 diabetes patients is significantly associated with an increase in hemoglobin A1c (HbA1c) levels, suggesting poorer glycemic control compared to that with a normal sleep duration, with the relationship being U-shaped [84]. In another study both a short sleep duration (>5.5 and 5.5–6.4 h) and a long sleep duration (7.5–8.4 h) were associated with an increase in the risk of metabolic syndrome, insulin resistance, and high-sensitivity C-reactive protein in diabetic patients compared to those with 6.5–7.4 h of sleep [85]. These findings also concluded that sleep duration has a U-shaped relationship with metabolic syndrome and insulin resistance. A recent meta-analysis confirmed that short sleep (> 6 compared to 7 h) may increase the risk of type 2 diabetes by approximately 30% [86]. It has been proposed that sleep deprivation impairs insulin sensitivity and pancreatic β-cell function and glucose uptake by target cells, increasing insulin resistance and leading to type 2 diabetes [87-94]. Recent evidence suggests that the metabolic hormones leptin and ghrelin are involved in the relationship between sleep and dysregulation of insulin and glucose and increase the risk of diabetes [63, 68, 94-97]. Given the effects of sleep deficiency on leptin levels and metabolism, a short sleep duration may mediate its effects on incident diabetes through weight gain [98, 99] (Fig. 1).

Fig. 1.

Role of sleep restriction on leptin regulation in obesity and diabetes.

Fig. 1.

Role of sleep restriction on leptin regulation in obesity and diabetes.

Close modal

The reviews on the role of sleep restriction in the metabolic and endocrine alterations propose that a decreased sleep duration impairs glucose tolerance and insulin sensitivity, increases evening concentrations of cortisol and levels of ghrelin, decreases levels of leptin, and increases appetite and hunger [100, 101].

In contrast, a multiethnic study in a population at high risk for diabetes showed that a short sleep duration (≤5.5 h) was associated with an increase in leptin levels [75]. A study in diabetic patients showed that an insufficient sleep duration increased the level of leptin and insulin resistance compared to those with an appropriate sleep duration [102]. A laboratory-based sleep study showed that sleep restriction (5 nights of 4 h in bed) impaired glucose homeostasis and increased fasting and insulin levels [63]. Sleep restriction was associated with an increase in afternoon cortisol and leptin levels compatible with an increased insulin resistance [63]. It has been reported that a 1-h reduction in sleep duration was associated with a 7% elevation in leptin levels [65]. Furthermore, a study in rotating-shift-work women reported an inverse association between leptin levels and the risk of type 2 diabetes. However, there was no association between sleep duration, leptin levels, and diabetes [103].

Considering the role of leptin in regulation of energy consumption, a decrease in the production of leptin due to a lack of sleep may explain the contribution of adjustment of this hormone to obesity, decreased insulin sensitivity, and increased insulin resistance. It is noteworthy that elevation of serum leptin levels results in decreased leptin transport across the blood-brain barrier [104]. It has been indicated that when leptin reaches its threshold the blood-brain barrier limits the leptin transport from peripheral blood to the central nervous system, inhibiting its activity [105]. This condition may explain the elevation of leptin levels due to sleep restriction, where the effectiveness of it is attenuated. In this way, leptin resistance, characterized by a decreased response to leptin due to a reduced receptor expression, is another possible mechanism that explains elevated leptin levels in the blood but decreased leptin effects [28]. Thus, in the case of elevated plasma leptin levels it does not consistently reflect increased leptin efficacy and function in glucose homeostasis [28].

In summary, recent evidence indicates that an insufficient sleep duration, with an effect on leptin metabolism, may promote the development of type 2 diabetes through increased hunger/food intake and weight gain. Furthermore, leptin dysregulation contributes to decreased insulin secretion and sensitivity, increased insulin resistance and inflammation, and consequently an increased risk of diabetes mellitus. Several studies have investigated the role of a short sleep duration on leptin regulation; however, the findings regarding the role of leptin in diabetes as a consequence of sleep curtailment are conflicting and more studies with a larger sample size are required to confirm the previous findings.

We reviewed and discussed the probable mechanism underlying the effect of sleep duration on leptin regulation as the potential physiological mechanism underlying obesity and type 2 diabetes. Potential limitations of this work include the conflation of sleep quality and sleep duration where these were not always reported separately in the studies included in this review. Furthermore, this review was conducted as a narrative review and as such a quality appraisal of the included papers was not undertaken. Further work is required to compare the findings of both sleep quality and duration on leptin circulation related to obesity and diabetes.

The authors declare that there is no conflict of interest regarding the publication of this article.

There were no funding sources for this work.

Maryam Mosavat drafted this paper. Mitra Mirsanjari, Diana Arabiat, Aisling Smyth, and Lisa Whitehead reviewed and revised this work. All authors read and approved the final version of this article.

1.
Shan
Z
,
Ma
H
,
Xie
M
,
Yan
P
,
Guo
Y
,
Bao
W
, et al.
Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies
.
Diabetes Care
.
2015
Mar
;
38
(
3
):
529
37
.
[PubMed]
0149-5992
2.
Van Cauter
E
,
Spiegel
K
,
Tasali
E
,
Leproult
R
.
Metabolic consequences of sleep and sleep loss.
Sleep Med.
2008
Sep
;9(0 1): S23–8.
3.
Tobaldini
E
,
Fiorelli
EM
,
Solbiati
M
,
Costantino
G
,
Nobili
L
,
Montano
N
.
Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence
.
Nat Rev Cardiol
.
2019
Apr
;
16
(
4
):
213
24
.
[PubMed]
1759-5002
4.
Taheri
S
,
Lin
L
,
Austin
D
,
Young
T
,
Mignot
E
.
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index
.
PLoS Med
.
2004
Dec
;
1
(
3
):
e62
.
[PubMed]
1549-1277
5.
Heinzer
R
,
Vat
S
,
Marques-Vidal
P
,
Marti-Soler
H
,
Andries
D
,
Tobback
N
, et al.
Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study
.
Lancet Respir Med
.
2015
Apr
;
3
(
4
):
310
8
.
[PubMed]
2213-2600
6.
Park
C
,
Sim
CS
,
Sung
JH
,
Lee
J
,
Ahn
JH
,
Choe
YM
, et al.
Low Income as a Vulnerable Factor to the Effect of Noise on Insomnia
.
Psychiatry Investig
.
2018
Jun
;
15
(
6
):
602
12
.
[PubMed]
1738-3684
7.
Ruggiero
AR
,
Peach
HD
,
Gaultney
JF
.
Association of sleep attitudes with sleep hygiene, duration, and quality: a survey exploration of the moderating effect of age, gender, race, and perceived socioeconomic status
.
Health Psychol Behav Med
.
2019
Jan
;
7
(
1
):
19
44
. 2164-2850
8.
Hirshkowitz
M
,
Whiton
K
,
Albert
SM
,
Alessi
C
,
Bruni
O
,
DonCarlos
L
, et al.
National Sleep Foundation’s updated sleep duration recommendations: final report
.
Sleep Health
.
2015
Dec
;
1
(
4
):
233
43
.
[PubMed]
2352-7218
9.
Hirshkowitz
M
,
Whiton
K
,
Albert
SM
,
Alessi
C
,
Bruni
O
,
DonCarlos
L
, et al.
National Sleep Foundation’s sleep time duration recommendations: methodology and results summary
.
Sleep Health
.
2015
Mar
;
1
(
1
):
40
3
.
[PubMed]
2352-7218
10.
Van Cauter
E
,
Knutson
KL
.
Sleep and the epidemic of obesity in children and adults
.
Eur J Endocrinol
.
2008
Dec
;
159
Suppl 1
:
S59
66
.
[PubMed]
0804-4643
11.
Miguez
MJ
,
Bueno
D
,
Perez
C
.
Disparities in Sleep Health among Adolescents: The Role of Sex, Age, and Migration
.
Sleep Disord
.
2020
Jan
;
2020
:
5316364
.
[PubMed]
2090-3545
12.
Medic
G
,
Wille
M
,
Hemels
ME
.
Short- and long-term health consequences of sleep disruption
.
Nat Sci Sleep
.
2017
May
;
9
:
151
61
.
[PubMed]
1179-1608
13.
Itani
O
,
Jike
M
,
Watanabe
N
,
Kaneita
Y
.
Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression
.
Sleep Med
.
2017
Apr
;
32
:
246
56
.
[PubMed]
1389-9457
14.
Cappuccio
FP
,
Cooper
D
,
D’Elia
L
,
Strazzullo
P
,
Miller
MA
.
Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies
.
Eur Heart J
.
2011
Jun
;
32
(
12
):
1484
92
.
[PubMed]
0195-668X
15.
Cappuccio
FP
,
D’Elia
L
,
Strazzullo
P
,
Miller
MA
.
Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis
.
Diabetes Care
.
2010
Feb
;
33
(
2
):
414
20
.
[PubMed]
0149-5992
16.
Wang
Y
,
Mei
H
,
Jiang
YR
,
Sun
WQ
,
Song
YJ
,
Liu
SJ
, et al.
Relationship between duration of sleep and hypertension in adults: a meta-analysis
.
J Clin Sleep Med
.
2015
Sep
;
11
(
9
):
1047
56
.
[PubMed]
1550-9389
17.
Chaput
JP
,
McNeil
J
,
Després
JP
,
Bouchard
C
,
Tremblay
A
.
Short sleep duration as a risk factor for the development of the metabolic syndrome in adults
.
Prev Med
.
2013
Dec
;
57
(
6
):
872
7
.
[PubMed]
0091-7435
18.
Shen
X
,
Wu
Y
,
Zhang
D
.
Nighttime sleep duration, 24-hour sleep duration and risk of all-cause mortality among adults: a meta-analysis of prospective cohort studies
.
Sci Rep
.
2016
Feb
;
6
(
1
):
21480
.
[PubMed]
2045-2322
19.
Wu
Y
,
Zhai
L
,
Zhang
D
.
Sleep duration and obesity among adults: a meta-analysis of prospective studies
.
Sleep Med
.
2014
Dec
;
15
(
12
):
1456
62
.
[PubMed]
1389-9457
20.
Leng
Y
,
Cappuccio
FP
,
Wainwright
NW
,
Surtees
PG
,
Luben
R
,
Brayne
C
, et al.
Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-analysis
.
Neurology
.
2015
Mar
;
84
(
11
):
1072
9
.
[PubMed]
0028-3878
21.
Knutson
KL
,
Spiegel
K
,
Penev
P
,
Van Cauter
E
.
The metabolic consequences of sleep deprivation
.
Sleep Med Rev
.
2007
Jun
;
11
(
3
):
163
78
.
[PubMed]
1087-0792
22.
Klok
MD
,
Jakobsdottir
S
,
Drent
ML
.
The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review
.
Obes Rev
.
2007
Jan
;
8
(
1
):
21
34
.
[PubMed]
1467-7881
23.
Denver
RJ
,
Bonett
RM
,
Boorse
GC
.
Evolution of leptin structure and function
.
Neuroendocrinology
.
2011
;
94
(
1
):
21
38
.
[PubMed]
0028-3835
24.
Fantuzzi
G
,
Faggioni
R
.
Leptin in the regulation of immunity, inflammation, and hematopoiesis
.
J Leukoc Biol
.
2000
Oct
;
68
(
4
):
437
46
.
[PubMed]
0741-5400
25.
Wang
C
,
Guan
Y
,
Yang
J
.
Cytokines in the progression of pancreatic β-cell dysfunction
.
Int J Endocrinol
.
2010
;
2010
:
515136
.
[PubMed]
1687-8337
26.
Pan
W
,
Kastin
AJ
.
Leptin: a biomarker for sleep disorders?
Sleep Med Rev
.
2014
Jun
;
18
(
3
):
283
90
.
[PubMed]
1087-0792
27.
Zhou
Y
,
Rui
L
.
Leptin signaling and leptin resistance
.
Front Med
.
2013
Jun
;
7
(
2
):
207
22
.
[PubMed]
2095-0217
28.
Gruzdeva
O
,
Borodkina
D
,
Uchasova
E
,
Dyleva
Y
,
Barbarash
O
.
Leptin resistance: underlying mechanisms and diagnosis
.
Diabetes Metab Syndr Obes
.
2019
Jan
;
12
:
191
8
.
[PubMed]
1178-7007
29.
Meek
TH
,
Morton
GJ
.
Leptin, diabetes, and the brain
.
Indian J Endocrinol Metab
.
2012
Dec
;
16
(
9
Suppl 3
):
S534
42
.
[PubMed]
2230-8210
30.
Meek
TH
,
Morton
GJ
.
The role of leptin in diabetes: metabolic effects
.
Diabetologia
.
2016
May
;
59
(
5
):
928
32
.
[PubMed]
0012-186X
31.
Oda
N
,
Imamura
S
,
Fujita
T
,
Uchida
Y
,
Inagaki
K
,
Kakizawa
H
, et al.
The ratio of leptin to adiponectin can be used as an index of insulin resistance
.
Metabolism
.
2008
Feb
;
57
(
2
):
268
73
.
[PubMed]
0026-0495
32.
Zaletel
J
,
Barlovic
DP
,
Prezelj
J
.
Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with Type 2 diabetes
.
J Endocrinol Invest
.
2010
Sep
;
33
(
8
):
514
8
.
[PubMed]
0391-4097
33.
Mosavat
M
,
Omar
SZ
,
Tan
PC
,
Razif
MF
,
Sthaneshwar
P
.
Leptin and soluble leptin receptor in association with gestational diabetes: a prospective case-control study
.
Arch Gynecol Obstet
.
2018
Mar
;
297
(
3
):
797
803
.
[PubMed]
0932-0067
34.
Peelman
F
,
Waelput
W
,
Iserentant
H
,
Lavens
D
,
Eyckerman
S
,
Zabeau
L
, et al.
Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases
.
Prog Lipid Res
.
2004
Jul
;
43
(
4
):
283
301
.
[PubMed]
0163-7827
35.
Olson
CA
,
Hamilton
NA
,
Somers
VK
.
Percentage of REM sleep is associated with overnight change in leptin
.
J Sleep Res
.
2016
Aug
;
25
(
4
):
419
25
.
[PubMed]
0962-1105
36.
Licinio
J
,
Mantzoros
C
,
Negrão
AB
,
Cizza
G
,
Wong
ML
,
Bongiorno
PB
, et al.
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function
.
Nat Med
.
1997
May
;
3
(
5
):
575
9
.
[PubMed]
1078-8956
37.
Hirota
T
,
Morioka
T
,
Yoda
K
,
Toi
N
,
Hayashi
N
,
Maruo
S
, et al.
Positive association of plasma leptin with sleep quality in obese type 2 diabetes patients
.
J Diabetes Investig
.
2018
Sep
;
9
(
5
):
1100
5
.
[PubMed]
2040-1116
38.
Yamanaka
A
,
Beuckmann
CT
,
Willie
JT
,
Hara
J
,
Tsujino
N
,
Mieda
M
, et al.
Hypothalamic orexin neurons regulate arousal according to energy balance in mice
.
Neuron
.
2003
Jun
;
38
(
5
):
701
13
.
[PubMed]
0896-6273
39.
Sakurai
T
.
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
.
Nat Rev Neurosci
.
2007
Mar
;
8
(
3
):
171
81
.
[PubMed]
1471-003X
40.
Laposky
AD
,
Bradley
MA
,
Williams
DL
,
Bass
J
,
Turek
FW
.
Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice
.
Am J Physiol Regul Integr Comp Physiol
.
2008
Dec
;
295
(
6
):
R2059
66
.
[PubMed]
0363-6119
41.
Jahromi
AS
,
Zareian
P
,
Madani
A
. Association of insulin resistance with serum interleukin-6 and TNF-α levels during normal pregnancy. Biomark Insights.
2011
;6: BMI–S6150.
42.
Xu
LL
,
Shi
CM
,
Xu
GF
,
Chen
L
,
Zhu
LL
,
Zhu
L
, et al.
TNF-α, IL-6, and leptin increase the expression of miR-378, an adipogenesis-related microRNA in human adipocytes
.
Cell Biochem Biophys
.
2014
Nov
;
70
(
2
):
771
6
.
[PubMed]
1085-9195
43.
Timper
K
,
Brüning
JC
.
Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity
.
Dis Model Mech
.
2017
Jun
;
10
(
6
):
679
89
.
[PubMed]
1754-8403
44.
Amitani
M
,
Asakawa
A
,
Amitani
H
,
Inui
A
.
The role of leptin in the control of insulin-glucose axis
.
Front Neurosci
.
2013
Apr
;
7
:
51
.
[PubMed]
1662-4548
45.
D’souza
AM
,
Neumann
UH
,
Glavas
MM
,
Kieffer
TJ
.
The glucoregulatory actions of leptin
.
Mol Metab
.
2017
May
;
6
(
9
):
1052
65
.
[PubMed]
2212-8778
46.
Rosenbaum
M
,
Leibel
RL
.
20 years of leptin: role of leptin in energy homeostasis in humans
.
J Endocrinol
.
2014
Oct
;
223
(
1
):
T83
96
.
[PubMed]
0022-0795
47.
Minokoshi
Y
,
Toda
C
,
Okamoto
S
.
Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle
.
Indian J Endocrinol Metab
.
2012
Dec
;
16
(
9
Suppl 3
):
S562
8
.
[PubMed]
2230-8210
48.
Beccuti
G
,
Pannain
S
.
Sleep and obesity
.
Curr Opin Clin Nutr Metab Care
.
2011
Jul
;
14
(
4
):
402
12
.
[PubMed]
1363-1950
49.
Hakim
F
,
Wang
Y
,
Carreras
A
,
Hirotsu
C
,
Zhang
J
,
Peris
E
, et al.
Chronic sleep fragmentation during the sleep period induces hypothalamic endoplasmic reticulum stress and PTP1b-mediated leptin resistance in male mice
.
Sleep (Basel)
.
2015
Jan
;
38
(
1
):
31
40
.
[PubMed]
0302-5128
50.
Seetho
IW
,
Wilding
JP
.
Screening for obstructive sleep apnoea in obesity and diabetes—potential for future approaches
.
Eur J Clin Invest
.
2013
Jun
;
43
(
6
):
640
55
.
[PubMed]
0014-2972
51.
van der Lely
AJ
,
Tschöp
M
,
Heiman
ML
,
Ghigo
E
.
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin
.
Endocr Rev
.
2004
Jun
;
25
(
3
):
426
57
.
[PubMed]
0163-769X
52.
Zigman
JM
,
Elmquist
JK
.
Minireview: from anorexia to obesity—the yin and yang of body weight control
.
Endocrinology
.
2003
Sep
;
144
(
9
):
3749
56
.
[PubMed]
0013-7227
53.
Cummings
DE
,
Purnell
JQ
,
Frayo
RS
,
Schmidova
K
,
Wisse
BE
,
Weigle
DS
.
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
.
Diabetes
.
2001
Aug
;
50
(
8
):
1714
9
.
[PubMed]
0012-1797
54.
Spiegel
K
,
Tasali
E
,
Penev
P
,
Van Cauter
E
.
Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite
.
Ann Intern Med
.
2004
Dec
;
141
(
11
):
846
50
.
[PubMed]
0003-4819
55.
Fu
J
,
Wang
Y
,
Li
G
,
Han
L
,
Li
Y
,
Li
L
, et al.
Childhood sleep duration modifies the polygenic risk for obesity in youth through leptin pathway: the Beijing Child and Adolescent Metabolic Syndrome cohort study
.
Int J Obes
.
2019
Aug
;
43
(
8
):
1556
67
.
[PubMed]
0307-0565
56.
Li
M
,
Fu
J
,
Han
L
,
Li
G
,
Gao
S
,
Grant
SF
, et al.
Childhood Habitual Sleep Duration Modifies the Polygenic Risk for Obesity through Leptin Pathway—A Longitudinal Study. Diabetes
2018
Jul
;67 (supplement 1).
57.
Chaput
JP
,
Després
JP
,
Bouchard
C
,
Tremblay
A
.
Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study
.
Obesity (Silver Spring)
.
2007
Jan
;
15
(
1
):
253
61
.
[PubMed]
1930-7381
58.
Mullington
JM
,
Chan
JL
,
Van Dongen
HP
,
Szuba
MP
,
Samaras
J
,
Price
NJ
, et al.
Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men
.
J Neuroendocrinol
.
2003
Sep
;
15
(
9
):
851
4
.
[PubMed]
0953-8194
59.
Stern
JH
,
Grant
AS
,
Thomson
CA
,
Tinker
L
,
Hale
L
,
Brennan
KM
, et al.
Short sleep duration is associated with decreased serum leptin, increased energy intake and decreased diet quality in postmenopausal women
.
Obesity (Silver Spring)
.
2014
May
;
22
(
5
):
E55
61
.
[PubMed]
1930-7381
60.
Garaulet
M
,
Sánchez-Moreno
C
,
Smith
CE
,
Lee
YC
,
Nicolás
F
,
Ordovás
JM
.
Ghrelin, sleep reduction and evening preference: relationships to CLOCK 3111 T/C SNP and weight loss
.
PLoS One
.
2011
Feb
;
6
(
2
):
e17435
.
[PubMed]
1932-6203
61.
Motivala
SJ
,
Tomiyama
AJ
,
Ziegler
M
,
Khandrika
S
,
Irwin
MR
.
Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia
.
Psychoneuroendocrinology
.
2009
May
;
34
(
4
):
540
5
.
[PubMed]
0306-4530
62.
Schmid
SM
,
Hallschmid
M
,
Jauch-Chara
K
,
Born
J
,
Schultes
B
.
A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men
.
J Sleep Res
.
2008
Sep
;
17
(
3
):
331
4
.
[PubMed]
0962-1105
63.
Reynolds
AC
,
Dorrian
J
,
Liu
PY
,
Van Dongen
HP
,
Wittert
GA
,
Harmer
LJ
, et al.
Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men
.
PLoS One
.
2012
;
7
(
7
):
e41218
.
[PubMed]
1932-6203
64.
Simpson
NS
,
Banks
S
,
Dinges
DF
.
Sleep restriction is associated with increased morning plasma leptin concentrations, especially in women
.
Biol Res Nurs
.
2010
Jul
;
12
(
1
):
47
53
.
[PubMed]
1099-8004
65.
Hayes
AL
,
Xu
F
,
Babineau
D
,
Patel
SR
.
Sleep duration and circulating adipokine levels
.
Sleep (Basel)
.
2011
Feb
;
34
(
2
):
147
52
.
[PubMed]
0302-5128
66.
Pejovic
S
,
Vgontzas
AN
,
Basta
M
,
Tsaoussoglou
M
,
Zoumakis
E
,
Vgontzas
A
, et al.
Leptin and hunger levels in young healthy adults after one night of sleep loss
.
J Sleep Res
.
2010
Dec
;
19
(
4
):
552
8
.
[PubMed]
0962-1105
67.
Omisade
A
,
Buxton
OM
,
Rusak
B
.
Impact of acute sleep restriction on cortisol and leptin levels in young women
.
Physiol Behav
.
2010
Apr
;
99
(
5
):
651
6
.
[PubMed]
0031-9384
68.
Spiegel
K
,
Leproult
R
,
L’hermite-Balériaux
M
,
Copinschi
G
,
Penev
PD
,
Van Cauter
E
.
Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin
.
J Clin Endocrinol Metab
.
2004
Nov
;
89
(
11
):
5762
71
.
[PubMed]
0021-972X
69.
Fontenelle
LC
,
Feitosa
MM
,
Severo
JS
,
Freitas
TE
,
Morais
JB
,
Torres-Leal
FL
, et al.
Thyroid Function in Human Obesity: underlying Mechanisms
.
Horm Metab Res
.
2016
Dec
;
48
(
12
):
787
94
.
[PubMed]
0018-5043
70.
Xu
R
,
Huang
F
,
Zhang
S
,
Lv
Y
,
Liu
Q
.
Thyroid function, body mass index, and metabolic risk markers in euthyroid adults: a cohort study
.
BMC Endocr Disord
.
2019
Jun
;
19
(
1
):
58
.
[PubMed]
1472-6823
71.
Solanki
A
,
Bansal
S
,
Jindal
S
,
Saxena
V
,
Shukla
US
.
Relationship of serum thyroid stimulating hormone with body mass index in healthy adults
.
Indian J Endocrinol Metab
.
2013
Oct
;
17
(
7
Suppl 1
):
S167
9
.
[PubMed]
2230-8210
72.
Sanyal
D
,
Raychaudhuri
M
.
Hypothyroidism and obesity: an intriguing link
.
Indian J Endocrinol Metab
.
2016
Jul-Aug
;
20
(
4
):
554
7
.
[PubMed]
2230-8210
73.
Bosy-Westphal
A
,
Hinrichs
S
,
Jauch-Chara
K
,
Hitze
B
,
Later
W
,
Wilms
B
, et al.
Influence of partial sleep deprivation on energy balance and insulin sensitivity in healthy women
.
Obes Facts
.
2008
;
1
(
5
):
266
73
.
[PubMed]
1662-4025
74.
Charles
LE
,
Gu
JK
,
Andrew
ME
,
Violanti
JM
,
Fekedulegn
D
,
Burchfiel
CM
.
Sleep duration and biomarkers of metabolic function among police officers
.
J Occup Environ Med
.
2011
Aug
;
53
(
8
):
831
7
.
[PubMed]
1076-2752
75.
Brady
EM
,
Bodicoat
DH
,
Hall
AP
,
Khunti
K
,
Yates
T
,
Edwardson
C
, et al.
Sleep duration, obesity and insulin resistance in a multi-ethnic UK population at high risk of diabetes
.
Diabetes Res Clin Pract
.
2018
May
;
139
:
195
202
.
[PubMed]
0168-8227
76.
Van Cauter
E
,
Holmbäck
U
,
Knutson
K
,
Leproult
R
,
Miller
A
,
Nedeltcheva
A
, et al.
Impact of sleep and sleep loss on neuroendocrine and metabolic function
.
Horm Res
.
2007
;
67
Suppl 1
:
2
9
.
[PubMed]
0301-0163
77.
Gutiérrez-Repiso
C
,
Soriguer
F
,
Rubio-Martín
E
,
Esteva de Antonio
I
,
Ruiz de Adana
MS
,
Almaraz
MC
, et al.
Night-time sleep duration and the incidence of obesity and type 2 diabetes. Findings from the prospective Pizarra study
.
Sleep Med
.
2014
Nov
;
15
(
11
):
1398
404
.
[PubMed]
1389-9457
78.
Schultes
B
,
Schmid
S
,
Peters
A
,
Born
J
,
Fehm
HL
.
Sleep loss and the development of diabetes: a review of current evidence
.
Exp Clin Endocrinol Diabetes
.
2005
Dec
;
113
(
10
):
563
7
.
[PubMed]
0947-7349
79.
Lou
P
,
Zhang
P
,
Zhang
L
,
Chen
P
,
Chang
G
,
Zhang
N
, et al.
Effects of sleep duration and sleep quality on prevalence of type 2 diabetes mellitus: A 5-year follow-up study in China
.
Diabetes Res Clin Pract
.
2015
Jul
;
109
(
1
):
178
84
.
[PubMed]
0168-8227
80.
Jackson
CL
,
Redline
S
,
Kawachi
I
,
Hu
FB
.
Association between sleep duration and diabetes in black and white adults
.
Diabetes Care
.
2013
Nov
;
36
(
11
):
3557
65
.
[PubMed]
0149-5992
81.
Tan
X
,
Chapman
CD
,
Cedernaes
J
,
Benedict
C
.
Association between long sleep duration and increased risk of obesity and type 2 diabetes: A review of possible mechanisms
.
Sleep Med Rev
.
2018
Aug
;
40
:
127
34
.
[PubMed]
1087-0792
82.
Jike
M
,
Itani
O
,
Watanabe
N
,
Buysse
DJ
,
Kaneita
Y
.
Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression
.
Sleep Med Rev
.
2018
Jun
;
39
:
25
36
.
[PubMed]
1087-0792
83.
Azharuddin
M
,
Kapur
P
,
Adil
M
,
Ghosh
P
,
Sharma
M
.
The impact of sleep duration and sleep quality on glycaemic control in Asian population with type 2 diabetes mellitus: A systematic literature review and meta-analysis of observational studies
.
Clin Epidemiol Glob Health
.
2020
Mar
;
8
(
3
):
967
75
. 2452-0918
84.
Lee
SW
,
Ng
KY
,
Chin
WK
.
The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis
.
Sleep Med Rev
.
2017
Feb
;
31
:
91
101
.
[PubMed]
1087-0792
85.
Ohkuma
T
,
Fujii
H
,
Iwase
M
,
Ogata-Kaizu
S
,
Ide
H
,
Kikuchi
Y
, et al.
U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry
.
Metabolism
.
2014
Apr
;
63
(
4
):
484
91
.
[PubMed]
0026-0495
86.
Holliday
EG
,
Magee
CA
,
Kritharides
L
,
Banks
E
,
Attia
J
.
Short sleep duration is associated with risk of future diabetes but not cardiovascular disease: a prospective study and meta-analysis
.
PLoS One
.
2013
Nov
;
8
(
11
):
e82305
.
[PubMed]
1932-6203
87.
Wong
PM
,
Manuck
SB
,
DiNardo
MM
,
Korytkowski
M
,
Muldoon
MF
.
Shorter sleep duration is associated with decreased insulin sensitivity in healthy white men
.
Sleep (Basel)
.
2015
Feb
;
38
(
2
):
223
31
.
[PubMed]
0302-5128
88.
Wang
X
,
Greer
J
,
Porter
RR
,
Kaur
K
,
Youngstedt
SD
.
Short-term moderate sleep restriction decreases insulin sensitivity in young healthy adults
.
Sleep Health
.
2016
Mar
;
2
(
1
):
63
8
.
[PubMed]
2352-7218
89.
Rao
MN
,
Neylan
TC
,
Grunfeld
C
,
Mulligan
K
,
Schambelan
M
,
Schwarz
JM
.
Subchronic sleep restriction causes tissue-specific insulin resistance
.
J Clin Endocrinol Metab
.
2015
Apr
;
100
(
4
):
1664
71
.
[PubMed]
0021-972X
90.
Donga
E
,
van Dijk
M
,
van Dijk
JG
,
Biermasz
NR
,
Lammers
GJ
,
van Kralingen
KW
, et al.
A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects
.
J Clin Endocrinol Metab
.
2010
Jun
;
95
(
6
):
2963
8
.
[PubMed]
0021-972X
91.
Pyykkönen
AJ
,
Isomaa
B
,
Pesonen
AK
,
Eriksson
JG
,
Groop
L
,
Tuomi
T
, et al.
Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study
.
Diabetes Care
.
2012
Nov
;
35
(
11
):
2271
8
.
[PubMed]
0149-5992
92.
Damanti
S
,
Bourron
O
,
Doulazmi
M
,
Mandengue Sosso
AL
,
Nguyen-Michel
VH
,
Mariani
J
, et al.
Relationship between sleep parameters, insulin resistance and age-adjusted insulin like growth factor-1 score in non diabetic older patients
.
PLoS One
.
2017
Apr
;
12
(
4
):
e0174876
.
[PubMed]
1932-6203
93.
Chang
JK
,
Koo
M
,
Kao
VY
,
Chiang
JK
.
Association of sleep duration and insulin resistance in Taiwanese vegetarians
.
BMC Public Health
.
2012
Aug
;
12
(
1
):
666
.
[PubMed]
1471-2458
94.
Buxton
OM
,
Pavlova
M
,
Reid
EW
,
Wang
W
,
Simonson
DC
,
Adler
GK
.
Sleep restriction for 1 week reduces insulin sensitivity in healthy men
.
Diabetes
.
2010
Sep
;
59
(
9
):
2126
33
.
[PubMed]
0012-1797
95.
Grandner
MA
,
Seixas
A
,
Shetty
S
,
Shenoy
S
.
Sleep duration and diabetes risk: population trends and potential mechanisms
.
Curr Diab Rep
.
2016
Nov
;
16
(
11
):
106
.
[PubMed]
1534-4827
96.
Broussard
JL
,
Ehrmann
DA
,
Van Cauter
E
,
Tasali
E
,
Brady
MJ
.
Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study
.
Ann Intern Med
.
2012
Oct
;
157
(
8
):
549
57
.
[PubMed]
0003-4819
97.
Knutson
KL
,
Van Cauter
E
.
Associations between sleep loss and increased risk of obesity and diabetes
.
Ann N Y Acad Sci
.
2008
;
1129
(
1
):
287
304
.
[PubMed]
0077-8923
98.
Ayas
NT
,
White
DP
,
Al-Delaimy
WK
,
Manson
JE
,
Stampfer
MJ
,
Speizer
FE
, et al.
A prospective study of self-reported sleep duration and incident diabetes in women
.
Diabetes Care
.
2003
Feb
;
26
(
2
):
380
4
.
[PubMed]
0149-5992
99.
Yaggi
HK
,
Araujo
AB
,
McKinlay
JB
.
Sleep duration as a risk factor for the development of type 2 diabetes
.
Diabetes Care
.
2006
Mar
;
29
(
3
):
657
61
.
[PubMed]
0149-5992
100.
Zimberg
IZ
,
Dâmaso
A
,
Del Re
M
,
Carneiro
AM
,
de Sá Souza
H
,
de Lira
FS
, et al.
Short sleep duration and obesity: mechanisms and future perspectives
.
Cell Biochem Funct
.
2012
Aug
;
30
(
6
):
524
9
.
[PubMed]
0263-6484
101.
Gangwisch
JE
.
Epidemiological evidence for the links between sleep, circadian rhythms and metabolism
.
Obes Rev
.
2009
Nov
;
10
Suppl 2
:
37
45
.
[PubMed]
1467-7881
102.
Jain
SK
,
Kahlon
G
,
Morehead
L
,
Lieblong
B
,
Stapleton
T
,
Hoeldtke
R
, et al.
The effect of sleep apnea and insomnia on blood levels of leptin, insulin resistance, IP-10, and hydrogen sulfide in type 2 diabetic patients
.
Metab Syndr Relat Disord
.
2012
Oct
;
10
(
5
):
331
6
.
[PubMed]
1540-4196
103.
Wang
S
,
Fu
W
,
Jiang
Y
,
Deng
L
,
Zhou
S
,
Yang
L
.
Association of plasma leptin levels with type 2 diabetes in rotating shift work women
.
Biomed Res (Aligarh)
.
2017
Jan
;
28
(
1
).0970-938X
104.
Banks
WA
.
Role of the blood-brain barrier in the evolution of feeding and cognition
.
Ann N Y Acad Sci
.
2012
Aug
;
1264
(
1
):
13
9
.
[PubMed]
0077-8923
105.
Imayama
I
,
Prasad
B
.
Role of Leptin in Obstructive Sleep Apnea
.
Ann Am Thorac Soc
.
2017
Nov
;
14
(
11
):
1607
21
.
[PubMed]
2329-6933
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.